Kura Oncology KURA Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's operating lease right-of-use assets in other assets?
- Kura Oncology (KURA) reported operating lease right-of-use assets in other assets of $7.17M in Q1 2026.
- How has Kura Oncology's operating lease right-of-use assets in other assets changed year-over-year?
- Kura Oncology's operating lease right-of-use assets in other assets decreased by 12.0% year-over-year, from $8.14M to $7.17M.
- What is the long-term trend for Kura Oncology's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Kura Oncology's operating lease right-of-use assets in other assets has grown at a 2.9% compound annual growth rate (CAGR), from $6.33M to $7.3M.